←
BioIronSocial281 posts
BioIronSocial avatar

BioIronSocial

@BioIronSocial
◷ Joined November 2023▧ 116 Photos and videos
BioIronSocial avatar
BioIronSocial@BioIronSocial·12 Nov 2023

Welcome to BioIron Social! The International BioIron Society focuses on the biology and chemistry of iron metabolism, pathogenesis of iron disorders, and development of new diagnostics and therapeutics for patients with iron disorders. Find us at bioiron.org

Post attachment
BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 11

A unique opportunity for researchers, scientists, and physicians to exchange ideas, build collaborations, and network in the prestigious setting of Palazzo della Gran Guardia and the vibrant atmosphere of Verona, a UNESCO World Heritage city. See you in Verona! 🇮🇹

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

Dear BioIron friends & collealgues, The East-West Iron Club Meeting is just few weeks away! Join is in Orlando, Florida, USA - 21-22 October ewicmeeting.org/ Looking forward to seeing you all!!

Post attachment
BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

🚀 Takeaways This study reframes CAR T optimization by focusing on avidity engineering rather than receptor redesign. By using ferritin scaffolds to cluster antigens, CAR T cells achieve stronger and more durable responses—even in difficult, low-antigen settings.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

This strategy enhances cytotoxic effects even when antigen density is low and aids in addressing antigen escape and tumor heterogeneity. In preclinical studies, ferritin engagers enhance the expansion, persistence, and overall effectiveness of CAR T-cells against leukemia.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

🔑 Key highlights A ferritin-centered aggregation system increases the avidity of CAR T-cells by clustering target antigens, which enhances the formation and activation of immune synapses.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

This study introduces a novel strategy to boost CAR T avidity using engineered ferritin-based scaffolds, potentially overcoming resistance in refractory disease.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

🔬 Why it matters? CAR T-cell therapies have transformed treatment for leukemias, but many patients relapse due to insufficient antigen engagement or weak CAR T-cell persistence.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 6

Spotlight Paper! 📢 “Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias” Li et al., 2026. Cell.

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 5

💻 Online via Zoom 🔗 Please register at the link below: us02web.zoom.us/meeting/regi… After registration, participants will receive a confirmation email with the meeting link and to access the webinar 💻 Online via Zoom We look forward to welcoming you online!

BioIronSocial avatar
BioIronSocial@BioIronSocial·Oct 5

Prof. Leeuwenburgh’s research focuses on healthy longevity, aging biology, metabolism, and translational approaches to age-related diseases.